CancerAppy 

Artificial Intelligence to transform cancer drug development.

OWNER

Luis Martín (See Profile)

Sector

Biotech

Stage

Prototyping, preclinical

Country

Spain


Cancerappy develops AI algorithms based on accumulated data and neuronal networks solutions for use in clinical trials

Cancerappy provides ample ability to analyze multiple variables and manage all related data with cancer drug development

It has an innovative platform in the cloud and AI algorithms that provide productive solutions for personalized medicine

This information is confidential, do not share or copy.

Under evaluation at least till: 27th July

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar